Mualliflar

  • Yodgorova N.T., Mirvaliyeva N.R., Nabiyeva M.I.

##semicolon##

vaginal kandidoz, Candida albicans, OIV, probiotiklar, antifungal, flukonazol, klotrimazol, infektsiya.

##submission.citations##

Alexander Muacevic and John R Adler Lubna Mohammed,Gaurav Jha,Iana Malasevskaia et al. The Interplay Between Sugar and Yeast Infections: Do Diabetics Have a Greater Predisposition to Develop Oral and Vulvovaginal Candidiasis?Monitoring Editor:/ 2021 Feb 18.doi:10.7759/cureus.13407

Aliyev Sh.R, Muhamedov M.I va boshq. Mikrobiologiyadan labaratoriya mashg’ulotlariga doir qo’llanma 2013-yil.

Burns DN, Tuomala R, Chang BH,et al. Vaginal coloniza-tion or infection withCandida albicansin human immuno-de® ciency virus-infected women during pregnancy andduring the postpartum period. Women and Infants Transmission Study Group. Clin Infect Dis1997; 24:201±1011

de Leon EM, Jacober SJ, Sobel JD, Foxman B. Prevalence and risk factors for vaginal Candida colonization in women with type 1 and type 2 diabetes. BMC Infect Dis. Jan 30.2002doi:10.1186/1471-2334-2-1

Donders GG, Prenen H, Verbeke G, Reybrouck R.Am J.Impaired tolerance for glucose in women with recurrent vaginal candidiasis. Obstet Gynecol.2002 PMID: 12388993 DOI:10.1067/mob. 2002.126285

Duerr A, Sierra MF, Feldman J, Clarke LM, Ehrlich I, DeHovitz J. Immune compromise and prevalence of Candidavulvovaginitis in human immunode deficiency virus-infected women. Obstet Gynecol 1997; 90:252±69

Edwards Jr, J. E.; Schwartz, M. M.; Schmidt, C. S. et al. (2018-06-01). "A Fungal Immunotherapeutic Vaccine (NDV-3A) for Treatment of Recurrent Vulvovaginal Candidiasis-A Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial". Clinical Infectious Diseases. PubMed.gov. 66 (12): 1928–1936. doi:10.1093/cid/ciy185. PMC5982716. PMID 29697 7 8.

Flavia de Bernardis, Sofia Graziani, Flavio trelli. Candida vaginitis:virulence, host response and vaccine prospects. International society for human and animal mycology. Medical mycology 2018, 56,S26-S31, doi:10.10/93mmy/myx139)

Goswami R, Dadhwal V, Tejaswi S, et al.Species-specific prevalence of vaginal candidiasis among patients with diabetes mellitus and its relation to their glycaemic status. J Infect. 2000 Sep; 41(2): 162-6.doi: 10.1053/jinf.2000.0723

Gunther LS, Martins HP, Gimenes F, de Abreu ALP, Consolaro MEL, Estivalet TIEPrevalence of Candida albicans and non-albicans isolates from vaginal secretions: comparative evaluation of colonization, vaginal candidiasis and recurrent vaginal candidiasis in diabetic and non-diabetic women..Sao Paulo Med J. 2014; 132(2): 116-20. doi:10.1590/15 163180.2014.1322640

Hubertine M. E. Willems, Salman S. Ahmed,Junyan Liu, Zhenbo Xuand Brian M. Peters Vulvovaginal Candidiasis: A Current Understanding and Burning Questions 2020 Feb 25. doi:10.3390/j of6010027

Jack D Sobel MD Chief Vulvovaginal candidiasis: a comparison of HIV-positive and - negative women, Division of Infectious Diseases, Department of Internal Medicine, Wayne State University School of Medicine, Detroit, MI, International Journal of STD & AIDS2002;13: 358

Jane Carpenter, Ethel Burns, Lesley Smith Journal of midwifery and women’s health nov. 2021 doi:10.1111/jmwh.133326)

Kapiga SH, Lyamuya EF, Lwihula GK, Hunter DJ. Theincidence of HIV infection among women using familyplanning methods in Dares Salaam, Tanzania.AIDS1998;12:75±8410

Kendirci M, Koç AN, Kurtoglu S, Keskin M, Kuyucu T.J Pediatr Endocrinol Metab.Vulvovaginal candidiasis in children and adolescents with type 1 diabetes mellitus. 2004; doi: 10.1515/ jpem.2004.1 7.11.1545

M. CareyJulia A. Critchley; Stephen DeWilde; Tess Harris; Fay J. Hosking; Derek G. Cook Corresponding author: Iain M. Carey, i.carey@sgul. ac.uk. Diabetes Care2018;41(3):513–521 https://doi .org/10.2337/dc17-2131)

Martins N, Ferreira I C, Barros L, Silva S, Henriques M.Candidiasis: predisposing factors, prevention, diagnosis and alternative treatment. Mycopathologia.2014;177:223–240

Mr. Brett A. TORTELLI, B.A., Warren G. LEWIS, Ph.D., Jenifer E. ALLSWORTH, Ph.D., Mr. Nadum MEMBER-MENEH, B.S., Ms. Lynne R. FOSTER, B.S., Hilary E. RENO, M.D. Ph.D., Jeffrey F. PEIPERT, M.D., Ph.D., Justin C. FAY, Ph.D. and Amanda L. LEWIS, Ph.D. Associations between the vaginal microbiome and Candida colonization in women of reproductive age 2019 Oct 22. doi:10.1016/j.ajog.2019.10.008

Nikodém, Éva; Tamási, Béla; Mihalik, Noémi; Ostorházi, Eszter (1 January 2015). "Vulvovaginitis candidosában előforduló sarjadzógomba-speciesek" [Yeast species in vulvovaginitis candidosa]. Orvosi Hetilap (in Hungarian). 156 (1): 28–31. doi:10.1556/OH.2015.30081. PMID25544052.

Pappas, PG; Kauffman, CA; Andes, DR; Clancy, CJ; Marr, KA; Ostrosky-Zeichner, L; Reboli, AC; Schuster, MG; Vazquez, JA; Walsh, TJ; Zaoutis, TE; Sobel, JD (16 December 2015). "Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America". Clinical Infectious Diseases. 62 (4): e1-50. doi:10.1093/cid/civ933. PMC4725385. PMID 2667 9628

Pizga Kumwenda, Fabien Cottier, Alexandra C. Hendry, Davey Kneafsey, Ben Keevan,1 Hannah Gallagher,1 Hung-Ji Tsai,1 and Rebecca A. Hall1. 1Institute of Microbiology and Infection, School of Biosciences, University of Birmingham, Birmingham B15 2TT, UK 2Kent Fungal Group, Division of Natural Sciences, School of Biosciences, University of Kent, Canterbury CT2 7NJ, UK 3Lead contact *Correspondence: r.a.hall@kent.ac.uk https://doi.org/10.1016/ j.celrep.2021.110183

Roberts, CL; Algert, CS; Rickard, KL; Morris, JM (21 March 2015). "Treatment of vaginal candidiasis for the prevention of preterm birth: a systematic review and meta-analysis". Systematic Reviews. 4: 31. doi:10.1186/s13643-015-0018-2. PMC 4373465. PMID 25874659.]

Robyn Horsager, Boehrer M.D. Obstetrics and Gynecology/DOI:10.1097/00006250-1994060 00-00011 20. September 20, 2022)

Rodrigues CF, Rodrigues ME, Henriques M.J Candida sp. infections in patients with diabetes mellitus. Clin Med.2019; 8:76.

Schuman P, Sobel JD, Ohmit SE,et al. Mucosal candidalcolonization and candidiasis in women with or at risk forhuman immunode® ciency virus infection. HIV Epidemiol-ogy Research Study (HERS) Group.Clin Infect Dis1998;27:1161±78

Seyedmojtaba Seyedmousavi, Sandra de M G Bosco, Sybren de Hoog, Frank Ebel, Daniel Elad, Renata R Gomes, Ilse D Jacobsen, Henrik E Jensen, An Martel, Bernard Mignon Medical Mycology, Volume 56, Issue suppl_1, April 2018, Pages S26–S31, https://doi.org/10.1093/mmy/myx139

Skoczylas, MM; Walat, A; Kordek, A; Loniewska, B; Rudnicki, J; Maleszka, R; Torbé, A (2014). "Congenital candidiasis as a subject of research in medicine and human ecology". Annals of Parasitology. 60 (3): 179–89. PMID25281815.)

Sobel JD, Ohmit SE, Schuman P,et al. The evolution of Candidaspp. and ̄ uconazole susceptibility among oral and InfectDis2001;183:286±9312

Sobel, JD (9 June 2007). "Vulvovaginal candidosis". Lancet. 369 (9577): 1961–71. doi:10.1016/ S0140-6736(07)60917-9. PMID17560449. S2CID3 3894309.

Spinillo A, Michelone G, Cavanna C, Colonna L, Capuzzo E,Nicola S. Clinical and microbiological characteristics ofsymptomatic vulvovaginal candidiasis in HIV-seropositive women. Genitourin Med 1994; 70:268±72

Workowski KA, Berman SM (August 2006). "Sexually transmitted diseases treatment guidelines, 2006". MMWR Recomm Rep. 55 (RR-11): 1–94. PMID16888612. Archived from the original on 2014-10-20.